Sarepta Therapeutics said it received approval from the Food & Drug Administration to update prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy.
Investor's Business Daily on MSN
Stock Market Today: Dow Climbs Off Lows; Drug Stock Doubles On Merck Deal (Live Coverage)
The Dow Jones industrials still held a loss of 0.3% after the index pared a steeper loss. Blue-chip stocks like Nvidia NVDA, ...
The Canadian Grain Commission reported canola exports for the week ended Nov. 9 were 121,200 tonnes, down from the previous week's 188,400. The year-to-date total reached 1.54 million tonnes, compared ...
US stocks declined on Friday (November 14), extending losses after Wall Street recorded its worst session in over a month.
Mexico first signed up for the pre-approved credit line in 2009 during the global financial crisis, and has maintained it as a precautionary measure without drawing on it. The renewal is for $24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results